what are the Recommendations for Bridging Therapy During Interruption of Oral
Anticoagulation in Patients With Prosthetic Heart Valves
(Continued)?
For patients with bioprosthetic heart valves or annuloplasty rings who are receiving anticoagulation for AF, it is reasonable to consider the need for bridging anticoagulant therapy around the time of invasive procedures on the basis of the CHADS-VASc score 2 2 weighed against the risk of bleeding.